Publications by authors named "Yuma Goto"

Claim this Profile
C
Clinical features of medication-related osteonecrosis of the jaw in prostate cancer management.
Yuma Goto, Fumihiko Urabe, Yue Ogihara, Mana Nakata, Juria Nakano

BJU Int· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Satapathy et al.
Fumihiko Urabe, Yuma Goto, Takahiro Kimura

BJU Int· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Cystoscopic Surveillance Schedule Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Yuhei Koike, Fumihiko Urabe, Katsuki Muramoto, Yuma Goto, Kosuke Iwatani

Clin Genitourin Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral vas deferens suturing to prevent inguinal hernias after radical prostatectomy.
Kenichi Hata, Yuma Goto, Masaki Hashimoto, Yusuke Takahashi, Yuki Takiguchi

BJUI Compass· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective study.
Fumihiko Urabe, Yuki Taneda, Naoki Uchida, Hirokazu Kagawa, Katsuki Muramoto, Yuma Goto

Jpn J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving Complete Response in Metastatic Prostate Cancer With Triplet Therapy and Local Radiation: A Case Report.
Katsuki Muramoto, Fumihiko Urabe, Keigo Sakanaka, Hajime Onuma, Soshi Kadena, Yuma Goto

Cureus· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of optimal timing and therapeutic efficacy of radium-223 therapy for metastatic castration-resistant prostate cancer: a multicenter collaborative study.
Fumihiko Urabe, Soshi Kadena, Kojiro Tashiro, Kenichi Tokuoka, Yuki Taneda, Yuma Goto

Jpn J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of remarkable response to combined radiation therapy, enfortumab vedotin, and pembrolizumab in metastatic urothelial carcinoma.
Fumihiko Urabe, Keigo Sakanaka, Mana Nakata, Yuma Goto, Katsuki Muramoto

Int Cancer Conf J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete Response Case of Metastatic Hormone-Sensitive Prostate Cancer Treated With Triplet Therapy (Androgen Deprivation Therapy + Docetaxel + Darolutamide).
Tatsuya Shimomura, Fumihiko Urabe, Hajime Onuma, Keigo Sakanaka, Soshi Kadena, Yuma Goto

Cureus· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal timing for initiating androgen receptor signaling inhibitor therapy in patients with nonmetastatic castration-resistant prostate cancer: a multicenter collaborative study.
Shuhei Hara, Fumihiko Urabe, Kojiro Tashiro, Yuma Goto, Yuya Iwamoto

Jpn J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter study.
Fumihiko Urabe, Yu Imai, Yuma Goto, Kojiro Tashiro, Masaki Hashimoto

Jpn J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a variant histology on the oncological outcomes of Japanese patients with upper tract urothelial carcinomas after radical nephroureterectomy: a multicenter retrospective study.
Naoki Uchida, Fumihiko Urabe, Yushi Suhara, Yuma Goto, Kentaro Yoshihara

Transl Androl Urol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study.
Hirokazu Kagawa, Fumihiko Urabe, Yuria Kiuchi, Kota Katsumi, Ryotaro Yamaguchi, Yuma Goto

Int J Clin Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective study.
Kazuhiro Takahashi, Fumihiko Urabe, Yushi Suhara, Juria Nakano, Kentaro Yoshihara, Yuma Goto

Jpn J Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic Polymer Free Volume Monitored by Single-Molecule Spectroscopy of a Dual Fluorescent Flapping Dopant.
Yuma Goto, Shun Omagari, Ryuma Sato, Takuya Yamakado, Ryo Achiwa

J Am Chem Soc· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory xenobiotic responsive elements in the distal 5'-flanking region of the mouse Cyp1a2 gene required for transcriptional activation by 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Yuki Kawasaki, Tsutomu Sakuma, Yuma Goto, Nobuo Nemoto

Drug Metab Dispos· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis